Fc binding fragments comprising an OX40 antigen-binding site
US12297283B2 · kind B2 · utility
0Cited by
20References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2019 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | May 22, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application relates to specific binding members that bind OX40. The specific binding members comprise an OX40 antigen-binding site located in a constant domain of the specific binding member and find application in the treatment of cancer and infectious diseases, for example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.